Um, yeah. It isnt an "accident". But it is not necessarily a big deal either. It certainly does not mean a big announcement is imminent, as you are insinuating.
They are at the same address because RCPI consolidated management, remember? Its a cost savings measure. It makes sense. Mullan runs Roskamp. SRQBio, LLC is a wholly owned subsidiary OF Roskamp. So yeah the work together. Crawford is part of SRQBio.
We know already that Roskamp and RCPI have been "partners". And what has the PPS done since their partnership? Lost about 97% from the highs.
So this is a pointless discussion - just more pump. Hopefully there is big news, but this is certainly not part of it.
Heres the fully thing. Since this post in Nov 2011, RMBS is a triple from the lows. And really a solid double.
RCPI? Well in the same timeframe its approx a 97% loss.
Either does RCPI.
Racist Franco/Pharma, I love the fact that youre broke on this stock. That you feel the need to mindlessly post day after day with 15 different handles trying to pump away on this stock.
Then with one fact filled post, a rational investor can outdo any nonsense you can conjure up.
Your only weapon, distract and deflect with politics, racism, etc.
Your BS is as transparent as your savings account.
Sentiment: Strong Sell
I have an answer thats funnier. All the cash you have lost! LOL!
If you spent half the time thinking about who I vote for than you do about your stocks, well, you know.
I realize you are always so interested in me, but how many times do I have to tell you, Im straight. All this attention seeking wont work. Good news though, when a Democrat makes it into the White house again, Im sure the stock market will triple once more and marriage equality will stay the law of the land. Still it sadly wont help RCPI.
Even if this is the case, HOW does this change your situation?
How does blaming shorts make you money?
If that worked, every fact-challenged long here would be a millionaire by now.
Good point yes.
I dont get why anyone would put hard earned cash into this, other than a short term swing. Why not wait until the picture is clearer? The risks far outweigh the rewards at this juncture, and they have for a long while. Turns out that strategy WAS the right one.
I mean who cares what the purpose of an overseas phase 1 trial is when your cash runs out in days or weeks? Sometimes the best thing you can do is sit and wait.
100% agreement. Product worked for me, and I find it unlikely shareholders of RCPI will benefit from any breakthroughs down the road.
One simply has to read the latest 10-q to see why.
Money runs out in June. More dilution will be needed. The company has not been profitable in 12 years, and is many many years from being profitable again. This assumes, of course things go perfectly with studies, which is no guarantee.
And my personal favorite, JW emailing the company in March saying he is due a severance package. For what ??!! Scandals, ruining shareholder value, nepotism and many years of million dollar salaries despite 12 years of losses. Again, JW could make a welfare queen blush.
When there is another dilution, if its major or negative headline hit, its possible the stock could slip below $1 a share again even after the split.
Again the shame of it all is I do believe they have "something". I personally loved the product. Unfortunately management greed and entitlement got in the way IMO.
None of what you said surprises me. I loved the product. It was the management and the way the company was run that I couldnt stand anymore. Talk about putting the cart before the horse, management paid themselves before success all on the backs of shareholders. Since where is that Entrepreneurial? Thats corporate welfare and entitlement, not capitalism.
Its my hope that some other firm takes over the patents or the ideas and runs with it in supplement form. Otherwise even if by some miracle this is FDA approved, it will likely be 7 years or more before anyone can use it.
Yep. its why I got out. Despite the fact that the product worked for me, I knew that Pharma is a long road. I always thought there could be hope with the supplement, however "hockey stick" growth in revenue failed to materialize. Then once the product was gone, that was is it. There is no real patent protection at this point (JW has many of those that do exist), the cash situation is abysmal and the data trials are far too early. Who needs shorts with all that, especially considering the value is still in the multi millions of dollar range. Still room to drop if there are setbacks, and a slow bleed is also possible if no real positive stories develop and there is a new vacuum.
Um, because they are a financial journal?
If you dont want bad news, dont have any. Tongue in cheek of course, but to hear that someone secretly gave a response to the FDA without several management and board members knowing isnt exactly a sign of good things going on in RCPI management.
Maybe the real question shouldnt be that the Wall street journal is at fault for negative slant articles (always the medias fault), but rather that maybe, just maybe, RCPI still has issues. Perhaps, just perhaps, it isnt just some big conspiracy, but instead the news is true.
Color me crazy, I know.
Now kudos for the reverse split, but come on, get it together mgt.
If by doomed you mean a 140%+ gain, just like the nasdaq has done under Obama, then I say, bring on the doom.
Must be all that socialism.
HA! Always a source of entertainment, the nonsensical wild theories. This all at 10 cents a share.
Im guessing voting chapman back in is a good move for the shorts. More of the same. Besides the "who do we replace him with" theory always stands. Amazing. Someone fails for years, and the only excuse to keep is either A, hes the best we can get or B who else would want the job? A formula for mediocrity.
Then theres the "well he deferred his salary". Yeah like that worked out great for Shareholders in regards to Perito.
Ah well, moot point anyway, Im sure the cronies will vote him back in. Retail has no control over this company, and there in lies the problem. Its all just an ATM for management, success or failure, funded my the minority retail shareholder.
Interesting. Im glad to see shareholders fighting for THEIR company. Like you said, Chapman heads up compensation and had 'contacts' at the FDA? Time for the boot.
Especially with management getting their comp from shares. I wonder if Perito is selling considering RCPI is 600k behind in paying his $2.5m bonus. Not sure if he would even have to disclose at this point.
I agree with much of what you say, except for the product. Yes, it did work for me and it worked well.
I dont doubt that JW is a swindler, but he did make a good product.
The problem was, of course, he basically robbed shareholders for years IMO.
Million dollar salaries, jets cars, perks etc etc etc all the while shareholders paid the bills. He loved the shortcut too apparently as evidence by the political mess that was his, and RCPIs, downfall.
Get paid now and if you make it big, all the better. Entitlement at its worst, just like a welfare queen spending her checks on the lotto.
While alboc worked for me, I dont doubt there is still much to flesh out with studies. All those claims of curing this that and the other were just that - claims. Still I think there was potential enough to study. Whether or not we ever find out, thats TBD, but I would guess that RCPI wont be the company that finds out.
Did you look at the 14a filing on Friday? A lot of revealing compensation information in there.
Some of my favorites - over $148k in AUTO expenses for select executives in 2014. Perito himself got 50k in Auto perks along with 23k in Club memberships. Two employees - mullan and chapman made 900k combined and in all 5 execs made close to $1.5m in salary. What did shareholders get for that? Why a discontinuation of their only viable product, delays in study filings and a 90% drop in share price. Now again Im not against paying someone a fair salary or a good buck, but this has been a train wreck. And 600k for a CEO of a company YEARS from product seems excessive, especially given the history. Also the fact that perito had so many perks even at the end, it does go to show all the nonsense that went on here with execs for the better part of a decade.
It seems, however, the well has run dry. They are 600k behind in Peritos $2.5m bonus which was to be paid in 8 installments. Behind in others too. Current execs deferred too.
So part of the ASH meeting in April is discuss exec compensation. Much of the salaries in short term now seem to be share price driven. Now normally I would cheer that, however based on past behavior, I dont exactly trust the intention here. If I were a shareholder, if there is some sort of price rise I would watch CLOSELY what execs do. There may be some serious selling, as perito and others sell hard to get blood from a stone.
That rise (pump?) may come just prior to ASH meeting – they will want a cheery mood, followed, perhaps by a lot of selling. Soon after is where I would keep an eye on exec selling.
One other beauty in all of this. Part of the objective at the ASH vote for exec compensation is to design compensation packages to attract and retain individuals with superior ability and managerial talent. Nice. With that kind of talent, why do shareholders need enemies?
Ill say it again. Entitlement.